title: Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention.
abstract: Slow or no-reflow phenomenon (SNR) complicates 10%-15% of cases of percutaneous intervention (PCI) in aortocoronary saphenous vein grafts (SVG). At present, there are no uniform, effective strategies to predict or prevent this common and potentially serious complication. The purpose of our study was to characterize variables correlated with the risk of SNR in SVG PCI in the era of stenting and glycoprotein IIb/IIIa receptor inhibitors. We identified 2,898 consecutive patients who had PCI, of whom 163 underwent PCI of at least one SVG. The clinical and angiographic characteristics of patients who developed SNR (SNR group) were compared with those who did not (no-SNR group). A total of 23 patients experienced SNR and 140 did not. Using a stepwise multivariate logistic regression analysis, four independent predictors for SNR were detected: probable thrombus (OR 6.9; 95% CI, 2.1-23.9; P = 0.001), acute coronary syndromes (OR 6.4; 95% CI, 2.0-25.3; P = 0.003), degenerated vein graft (OR 5.2; 95% CI, 1.7-16.6; P = 0.003), and ulcer (OR 3.4; 95% CI, 0.99-11.6; P = 0.04). The risk of developing SNR could be estimated according to the number of predictors found: low-grade risk (1%-10%) if < or = one variable was present, moderate risk (20%-40%) if two variables were present, and high risk (60%-90%) if three or more variables were present. We identified and quantified current risk factors for SNR and concluded that the risk of developing SNR during PCI in SVG can be predicted by simple clinical and angiographic variables obtained before PCI. This information may be useful when the risk of PCI has to be balanced against alternative strategies such as medical therapy or redo-bypass surgery or in the selection of those patients that will most benefit from the use of protection devices during PCI.
authors.affiliation: Cardiology Division, Department of Medicine, University of Texas Medical School, Houston, Texas 77030, USA.
authors.forename: S
authors.initials: S
authors.lastname: Sdringola
authors.forename: A R
authors.initials: AR
authors.lastname: Assali
authors.forename: M
authors.initials: M
authors.lastname: Ghani
authors.forename: A
authors.initials: A
authors.lastname: Moustapha
authors.forename: H
authors.initials: H
authors.lastname: Achour
authors.forename: S W
authors.initials: SW
authors.lastname: Yusuf
authors.forename: K
authors.initials: K
authors.lastname: Fujise
authors.forename: O
authors.initials: O
authors.lastname: Rosales
authors.forename: G W
authors.initials: GW
authors.lastname: Schroth
authors.forename: H V
authors.initials: HV
authors.lastname: Anderson
authors.forename: R W
authors.initials: RW
authors.lastname: Smalling
mesh_terms: D000368:Aged; D001011:Aorta / Q000601:surgery*; D001026:Coronary Artery Bypass / Q000295:instrumentation; D003331:Coronary Vessels / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012501:Saphenous Vein / Q000601:surgery*; D015607:Stents; D013781:Texas; D016896:Treatment Outcome